UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 3.324

Sortiert nach

Non-small-cell lung cancers: a heterogeneous set of diseases

Nature reviews. Cancer, 2014-08, Vol.14 (8), p.535

2014

Link zum Volltext

Verfügbarkeit prüfen

Real‐world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non–small cell lung cancer

Cancer, 2019-11, Vol.125 (22), p.4019-4032

2019

Link zum Volltext

Verfügbarkeit prüfen

The evolution of lung cancer and impact of subclonal selection in TRACERx

Nature (London), 2023-04, Vol.616 (7957), p.525-533

2023

Link zum Volltext

Verfügbarkeit prüfen

LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway

Molecular cancer, 2021-12, Vol.20 (1), p.156-156, Article 156

2021

Link zum Volltext

Verfügbarkeit prüfen

FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway

Genome medicine, 2020-09, Vol.12 (1), p.77-27, Article 77

2020

Link zum Volltext

Verfügbarkeit prüfen

Tumor-Associated Macrophages Enhance Tumor Hypoxia and Aerobic Glycolysis

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4), p.795-806

2019

Link zum Volltext

Verfügbarkeit prüfen

The National Lung Matrix Trial of personalized therapy in lung cancer

Nature (London), 2020-07, Vol.583 (7818), p.807-812

2020

Link zum Volltext

Verfügbarkeit prüfen

Mechanistic links between COPD and lung cancer

Nature reviews. Cancer, 2013-04, Vol.13 (4), p.233

Houghton, A McGarry

2013

Link zum Volltext

Verfügbarkeit prüfen

Overall survival prediction of non-small cell lung cancer by integrating microarray and clinical data with deep learning

Scientific reports, 2020-03, Vol.10 (1), p.4679, Article 4679

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of Antibiotics and Proton Pump Inhibitors on Efficacy and Tolerance of Anti-PD-1 Immune Checkpoint Inhibitors

Frontiers in immunology, 2021-10, Vol.12, p.716317-716317

2021

Link zum Volltext

Verfügbarkeit prüfen

Non-small-cell lung cancer

Nature reviews. Disease primers, 2015-05, Vol.1 (1), p.15009-15009, Article 15009

2015

Link zum Volltext

Verfügbarkeit prüfen

RASA1 and NF1 are Preferentially Co-Mutated and Define A Distinct Genetic Subset of Smoking-Associated Non-Small Cell Lung Carcinomas Sensitive to MEK Inhibition

Clinical cancer research, 2018-03, Vol.24 (6), p.1436-1447

2018

Link zum Volltext

Verfügbarkeit prüfen

Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non-Small Cell Lung Cancer

Clinical cancer research, 2019-08, Vol.25 (16), p.5061-5068

2019

Link zum Volltext

Verfügbarkeit prüfen

A composite biomarker of neutrophil-lymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers

BMC cancer, 2021-04, Vol.21 (1), p.441-441, Article 441

2021

Link zum Volltext

Verfügbarkeit prüfen

Addressing cellular heterogeneity in tumor and circulation for refined prognostication

Proceedings of the National Academy of Sciences - PNAS, 2019-09, Vol.116 (36), p.17957-17962

2019

Link zum Volltext

Verfügbarkeit prüfen

Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis

BMC cancer, 2019-04, Vol.19 (1), p.353-16, Article 353

2019

Link zum Volltext

Verfügbarkeit prüfen

The Fire Within: NF-κB Involvement in Non-Small Cell Lung Cancer

Cancer research (Chicago, Ill.), 2020-10, Vol.80 (19), p.4025-4036

2020

Link zum Volltext

Verfügbarkeit prüfen

Melatonin as a potential anticarcinogen for non-small-cell lung cancer

Oncotarget, 2016-07, Vol.7 (29), p.46768-46784

2016

Link zum Volltext

Verfügbarkeit prüfen

MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancer

Molecular cancer, 2021-09, Vol.20 (1), p.118-15, Article 118

2021

Link zum Volltext

Verfügbarkeit prüfen

Lung Cancer in Never Smokers: A Review

Journal of clinical oncology, 2007-02, Vol.25 (5), p.561-570

2007

Link zum Volltext

Verfügbarkeit prüfen

Lower airway bacterial microbiome may influence recurrence after resection of early-stage non–small cell lung cancer

The Journal of thoracic and cardiovascular surgery, 2021-02, Vol.161 (2), p.419-429.e16

2021

Link zum Volltext

Verfügbarkeit prüfen

Metformin in Conjunction With Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer: Long-term Results of a Prospective Phase II Clinical Trial

Anticancer research, 2024-01, Vol.44 (1), p.133

2024

Link zum Volltext

Verfügbarkeit prüfen

ANK1 Methylation regulates expression of MicroRNA-486-5p and discriminates lung tumors by histology and smoking status

Cancer letters, 2017-12, Vol.410, p.191-200

2017

Link zum Volltext

Verfügbarkeit prüfen

Toxicity with small molecule and immunotherapy combinations in non-small cell lung cancer

Cancer Immunology, Immunotherapy, 2021-03, Vol.70 (3), p.589-595

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 3.324

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.081)
Mit Volltextzugriff
(2.806)

Publikationsform

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(3.300)
Science & Technology
(2.727)
Life Sciences & Biomedicine
(2.677)
Male
(2.247)
Female
(2.007)
Middle Aged
(1.953)
Aged
(1.825)
Oncology
(1.667)
Lung Neoplasms - Pathology
(1.274)
Carcinoma, Non-Small-Cell Lung - Pathology
(1.084)
Lung Cancer
(1.036)
Adult
(984)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(939)
Lung Neoplasms - Drug Therapy
(928)
Aged, 80 And Over
(773)
Carcinoma, Non-Small-Cell Lung - Complications
(751)
Biological And Medical Sciences
(726)
Lung Neoplasms - Complications
(722)
Medical Sciences
(717)
Retrospective Studies
(696)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(16)

Menü

Weitere Dienste

Einstellungen

Non-small-cell lung cancers: a heterogeneous set of diseases

Real‐world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non–small cell lung cancer

The evolution of lung cancer and impact of subclonal selection in TRACERx

Low PD-1 Expression in Cytotoxic CD8 + Tumor-Infiltrating Lymphocytes Confers an Immune-Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value

LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway

FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway

Tumor-Associated Macrophages Enhance Tumor Hypoxia and Aerobic Glycolysis

The National Lung Matrix Trial of personalized therapy in lung cancer

Mechanistic links between COPD and lung cancer

Overall survival prediction of non-small cell lung cancer by integrating microarray and clinical data with deep learning

Impact of Antibiotics and Proton Pump Inhibitors on Efficacy and Tolerance of Anti-PD-1 Immune Checkpoint Inhibitors

Non-small-cell lung cancer

RASA1 and NF1 are Preferentially Co-Mutated and Define A Distinct Genetic Subset of Smoking-Associated Non-Small Cell Lung Carcinomas Sensitive to MEK Inhibition

Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non-Small Cell Lung Cancer

A composite biomarker of neutrophil-lymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers

Addressing cellular heterogeneity in tumor and circulation for refined prognostication

Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis

The Fire Within: NF-κB Involvement in Non-Small Cell Lung Cancer

Melatonin as a potential anticarcinogen for non-small-cell lung cancer

MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancer

Lung Cancer in Never Smokers: A Review

Lower airway bacterial microbiome may influence recurrence after resection of early-stage non–small cell lung cancer

Metformin in Conjunction With Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer: Long-term Results of a Prospective Phase II Clinical Trial

ANK1 Methylation regulates expression of MicroRNA-486-5p and discriminates lung tumors by histology and smoking status

Toxicity with small molecule and immunotherapy combinations in non-small cell lung cancer

Suchergebnisse filtern